Acceleron Pharma (United States)
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Acceleron Pharma (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
42%
Total
Publications
333
Total Open
Publications
141
Total
Citations
13K
Open Access
Percentage
42%
Total
Publications
333
Total Open
Publications
141
Total
Citations
13K
Breakdown
Publisher Open
10%
Both
22%
Other Platform Open
10%
Closed
58%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
27
Hybrid 28%
31
No Guarantees 47%
51
Other Platform Open
Domain 88%
93
Institution 20%
21
Other Internet 9%
10
Public 7%
7
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 93 |
Europe PMC | Domain | 65 |
DOI | Other Internet | 14 |
Semantic Scholar | Public | 6 |
University College London - UCL Discovery | Institution | 3 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 3 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 3 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 3 |
University of Florence - Florence Research | Institution | 2 |
CiteSeer X | Other Internet | 2 |